Increased Spinal Dynorphin Levels and Phospho-Extracellular Signal-Regulated Kinases 1 and 2 and c-Fos Immunoreactivity after Surgery under Remifentanil Anesthesia in Mice
Authors:
- Ana CampilloACAna Campillo
- Ana González-CuelloAGAna González-Cuello
- David CabañeroDCDavid Cabañero
- Paula Garcia-NogalesPGPaula Garcia-Nogales
- Asunción RomeroARAsunción Romero
- M. Victoria MilanésMMM. Victoria Milanés
- M. Luisa LaordenMLM. Luisa Laorden
- Margarita M. PuigMPMargarita M. Puig
- 1 February 2010
- journal article
- research article
- Published by Elsevier in Molecular Pharmacology
- Vol. 77 (2) , 185-194
Abstract
In humans, remifentanil anesthesia enhances nociceptive sensitization in the postoperative period. We hypothesized that activation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) and the expression of c-Fos, prodynorphin (mRNA), and dynorphin in the spinal cord could participate in the molecular mechanisms underlying postoperative opioid-induced sensitization. In a mouse model of incisional pain, we evaluated thermal (Hargreaves test) and mechanical (von Frey) hyperalgesia during the first 21 postoperative days. Moreover, prodynorphin (mRNA, real-time polymerase chain reaction), dynorphin (enzymatic immunoassay), c-Fos expression, and ERK1/2 phosphorylation (both by immunohistochemistry) in the lumbar spinal cord were assessed. Surgery performed under remifentanil anesthesia induced a maximal decrease in nociceptive thresholds between 4 h and 2 days postoperatively (p < 0.001) that lasted 10 to 14 days compared with noninjured animals. In the same experimental conditions, a significant increase in prodynorphin mRNA expression (at 2 and 4 days) followed by a sustained increase of dynorphin (days 2 to 10) in the spinal cord was observed. We also identified an early expression of c-Fos immunoreactivity in the superficial laminae of the dorsal horn of the spinal cord (peak at 4 h; p < 0.001), together with a partial activation of ERK1/2 (4 h; p < 0.001). These findings suggest that activated ERK1/2 could induce c-Fos expression and trigger the transcription of prodynorphin in the spinal cord. This in turn would result in long-lasting increased levels of dynorphin that, in our model, could participate in the persistence of pain but not in the manifestation of first pain.Keywords
This publication has 45 references indexed in Scilit:
- Pronociceptive Effects of Remifentanil in a Mouse Model of Postsurgical PainAnesthesiology, 2009
- The pro-nociceptive effects of remifentanil or surgical injury in mice are associated with a decrease in delta-opioid receptor mRNA levels: Prevention of the nociceptive response by on-site delivery of enkephalinsPain, 2009
- Opioid-induced Hyperalgesia in a Murine Model of Postoperative PainAnesthesiology, 2006
- Opioid-induced HyperalgesiaAnesthesiology, 2006
- Role of PKC‐α,γ isoforms in regulation of c‐Fos and TH expression after naloxone‐induced morphine withdrawal in the hypothalamic PVN and medulla oblongata catecholaminergic cell groupsJournal of Neurochemistry, 2005
- A polymeric membrane dressing with antinociceptive properties: analysis with a rodent model of stab wound secondary hyperalgesiaThe Journal of Pain, 2004
- Short-term infusion of the μ-opioid agonist remifentanil in humans causes hyperalgesia during withdrawalPain, 2003
- No DREAM, No PainCell, 2002
- Characterization of a rat model of incisional painPain, 1996
- Quantitative assessment of tactile allodynia in the rat pawJournal of Neuroscience Methods, 1994